Drug · DIN 02447363
AMITIZA
SOFTGEL CAPSULES
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since December 17, 2020.
- Drug Identification Number (DIN)
- 02447363
- Company (DIN owner)
- Sucampo Pharma Americas LlcBedminster, New Jersey, United States
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Lubiprostone A06AX03
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LUBIPROSTONE | 24 MCG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 14, 2015: NOC 17380New Drug Submission (NDS)